Showing results (91-100 of 1,226) with videos related to
Sort By:
Pageof 123
American Heart Journal|August 2, 2003
Role of lipid and lipoprotein profiles in risk assessment and therapyChristie M Ballantyne, Ron C HoogeveenThe Physician and Sportsmedicine|July 16, 2010
METEOR Trial Reports on the Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals with Subclinical AtherosclerosisRudy M Haddad, Christie M BallantyneClinical Cornerstone|February 14, 2006
Cardiometabolic risk assessment: an approach to the prevention of cardiovascular disease and diabetes mellitusAbu R Vasudevan, Christie M BallantyneCanadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|April 1, 1994
Chronic benign retinal pigment epithelial detachment: a subtype of central serous choroidopathyK Lachapelle, M Ballantyne, A CruessPreventive Cardiology|February 6, 2002
The evolving role of high-density lipoprotein in reducing cardiovascular riskC M Ballantyne, G R RangarajThe American Journal of Cardiology|December 7, 2002
Combination therapy for combined dyslipidemiaAntonios M Xydakis, Christie M BallantyneClinical Chemistry|December 1, 2020
Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and InflammationRon C Hoogeveen, Christie M BallantyneAtherosclerosis|May 23, 2022
Existing and emerging strategies to lower Lipoprotein(a)Gregory G Schwartz, Christie M BallantyneProgress in Cardiovascular Diseases|October 28, 1998
Defining specific goals of therapy in treating dyslipidemia in the patient with low high-density lipoprotein cholesterolL M Belalcazar, C M BallantyneNature Reviews. Cardiology|June 25, 2014
Lipid lowering with PCSK9 inhibitorsRazvan T Dadu, Christie M BallantynePageof 123